Quantum Biopharma Ltd.
Develops therapies for brain disorders and a functional beverage for post-alcohol wellness.
QNTM | NDAQ
Overview
Corporate Details
- ISIN(s):
- CA74764Y2050 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 55 UNIVERSITY AVENUE, SUITE 1003, TORONTO
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Quantum BioPharma Ltd. is a biopharmaceutical company that develops novel solutions for brain and inflammatory disorders. The company's primary focus is on its therapeutic pipeline for neurodegenerative and neuropsychiatric diseases. Its lead candidate, Lucid-MS, is a patented, first-in-class new chemical entity for the treatment of Multiple Sclerosis (MS) that has completed Phase-1 first-in-human safety and tolerability trials. In addition to its core pharmaceutical research, Quantum BioPharma is also launching unbuzzd™, a science-backed functional beverage designed to support wellness after alcohol consumption, led by a separate team with extensive experience in the beverage industry.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Quantum Biopharma Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Quantum Biopharma Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Quantum Biopharma Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
